9/01/2010
Celator^® Pharmaceuticals Raises $20 Million in Series D Financing

6/21/2010
Celator^® Pharmaceuticals expands research agreement with Cephalon, Inc.

6/14/2010
Celator^® Pharmaceuticals presents data on combining CPX-351 with Clofarabine or Azacytidine at the European Hematology Association Congress

6/07/2010
Celator^® Pharmaceuticals Announces data on remissions with CPX-351 following induction failure

5/03/2010
Celator^® Pharmaceuticals Announces Positive Data From Phase 2 Study of CPX-351 in Acute Myeloid Leukemia

4/22/2010
Celator^® Pharmaceuticals Presents New Data on Two Nano-scale Delivery Platforms at the American Association for Cancer Research

4/12/2010
Celator^® Pharmaceuticals Receives Notice of Allowance on U.S. Patent for CombiPlex® Technology Platform

2/17/2010
Celator^® Pharmaceuticals selected to participate in NCI's Nanotechnology Characterization Laboratory assay cascade for characterization of nanparticle prodrug delivery platform